458 related articles for article (PubMed ID: 16495286)
1. Economic burden of cardiovascular diseases in the enlarged European Union.
Leal J; Luengo-Fernández R; Gray A; Petersen S; Rayner M
Eur Heart J; 2006 Jul; 27(13):1610-9. PubMed ID: 16495286
[TBL] [Abstract][Full Text] [Related]
2. Cost of cardiovascular diseases in the United Kingdom.
Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
[TBL] [Abstract][Full Text] [Related]
3. Cost of dementia in the pre-enlargement countries of the European Union.
Luengo-Fernandez R; Leal J; Gray AM
J Alzheimers Dis; 2011; 27(1):187-96. PubMed ID: 21860095
[TBL] [Abstract][Full Text] [Related]
4. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
5. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
7. [Cost of cancer care in Portugal].
Araújo A; Barata F; Barroso S; Cortes P; Damasceno M; Parreira A; Espírito Santo J; Teixeira E; Pereira R
Acta Med Port; 2009; 22(5):525-36. PubMed ID: 19944035
[TBL] [Abstract][Full Text] [Related]
8. The economic costs of cardiovascular disease mortality in California, 1991: implications for public health policy.
Fox P; Gazzaniga J; Karter A; Max W
J Public Health Policy; 1996; 17(4):442-59. PubMed ID: 9009539
[TBL] [Abstract][Full Text] [Related]
9. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
10. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
11. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of cardiovascular diseases in the European Union: a population-based cost study.
Luengo-Fernandez R; Walli-Attaei M; Gray A; Torbica A; Maggioni AP; Huculeci R; Bairami F; Aboyans V; Timmis AD; Vardas P; Leal J
Eur Heart J; 2023 Dec; 44(45):4752-4767. PubMed ID: 37632363
[TBL] [Abstract][Full Text] [Related]
13. The direct and indirect costs of cardiovascular disease in South Africa in 1991.
Pestana JA; Steyn K; Leiman A; Hartzenberg GM
S Afr Med J; 1996 Jun; 86(6):679-84. PubMed ID: 8764427
[TBL] [Abstract][Full Text] [Related]
14. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
15. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of cardiovascular disease in Canada.
Chan B; Coyte P; Heick C
Can J Cardiol; 1996 Oct; 12(10):1000-6. PubMed ID: 9191493
[TBL] [Abstract][Full Text] [Related]
17. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
18. Economic Burden of Cardiovascular Diseases in the Russian Federation.
Kontsevaya A; Kalinina A; Oganov R
Value Health Reg Issues; 2013; 2(2):199-204. PubMed ID: 29702865
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.
Sobocki P; Pugliatti M; Lauer K; Kobelt G
Mult Scler; 2007 Sep; 13(8):1054-64. PubMed ID: 17623729
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R; Leal J; Sullivan R; Luengo-Fernandez R
Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
